• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾细胞癌中肿瘤细胞和巨噬细胞的铁代谢紊乱表型影响肿瘤生长。

The Disturbed Iron Phenotype of Tumor Cells and Macrophages in Renal Cell Carcinoma Influences Tumor Growth.

作者信息

Schnetz Matthias, Meier Julia K, Rehwald Claudia, Mertens Christina, Urbschat Anja, Tomat Elisa, Akam Eman A, Baer Patrick, Roos Frederik C, Brüne Bernhard, Jung Michaela

机构信息

Institute of Biochemistry I, Goethe-University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.

Institute for Biomedicine, Aarhus University, C. F. Møllers Allé 6, 8000 Aarhus, Denmark.

出版信息

Cancers (Basel). 2020 Feb 25;12(3):530. doi: 10.3390/cancers12030530.

DOI:10.3390/cancers12030530
PMID:32106629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7139531/
Abstract

Accumulating evidence suggests that iron homeostasis is disturbed in tumors. We aimed at clarifying the distribution of iron in renal cell carcinoma (RCC). Considering the pivotal role of macrophages for iron homeostasis and their association with poor clinical outcome, we investigated the role of macrophage-secreted iron for tumor progression by applying a novel chelation approach. We applied flow cytometry and multiplex-immunohistochemistry to detect iron-dependent markers and analyzed iron distribution with atomic absorption spectrometry in patients diagnosed with RCC. We further analyzed the functional significance of iron by applying a novel extracellular chelator using RCC cell lines as well as patient-derived primary cells. The expression of iron-regulated genes was significantly elevated in tumors compared to adjacent healthy tissue. Iron retention was detected in tumor cells, whereas tumor-associated macrophages showed an iron-release phenotype accompanied by enhanced expression of ferroportin. We found increased iron amounts in extracellular fluids, which in turn stimulated tumor cell proliferation and migration. In vitro, macrophage-derived iron showed pro-tumor functions, whereas application of an extracellular chelator blocked these effects. Our study provides new insights in iron distribution and iron-handling in RCC. Chelators that specifically scavenge iron in the extracellular space confirmed the importance of macrophage-secreted iron in promoting tumor growth.

摘要

越来越多的证据表明,肿瘤中的铁稳态受到干扰。我们旨在阐明肾细胞癌(RCC)中铁的分布情况。鉴于巨噬细胞在铁稳态中的关键作用及其与不良临床预后的关联,我们通过应用一种新型螯合方法研究了巨噬细胞分泌的铁对肿瘤进展的作用。我们运用流式细胞术和多重免疫组织化学检测铁依赖性标志物,并采用原子吸收光谱法分析了确诊为RCC患者的铁分布情况。我们还使用RCC细胞系以及患者来源的原代细胞,通过应用一种新型细胞外螯合剂进一步分析了铁的功能意义。与相邻的健康组织相比,肿瘤中铁调节基因的表达显著升高。在肿瘤细胞中检测到铁潴留,而肿瘤相关巨噬细胞表现出铁释放表型,同时伴有铁转运蛋白表达增强。我们发现细胞外液中的铁含量增加,这反过来又刺激了肿瘤细胞的增殖和迁移。在体外,巨噬细胞衍生的铁具有促肿瘤功能,而应用细胞外螯合剂则可阻断这些作用。我们的研究为RCC中铁的分布和铁处理提供了新的见解。特异性清除细胞外空间中铁的螯合剂证实了巨噬细胞分泌的铁在促进肿瘤生长中的重要性。

相似文献

1
The Disturbed Iron Phenotype of Tumor Cells and Macrophages in Renal Cell Carcinoma Influences Tumor Growth.肾细胞癌中肿瘤细胞和巨噬细胞的铁代谢紊乱表型影响肿瘤生长。
Cancers (Basel). 2020 Feb 25;12(3):530. doi: 10.3390/cancers12030530.
2
Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression.细胞内铁螯合作用调节巨噬细胞铁表型,对肿瘤进展产生影响。
PLoS One. 2016 Nov 2;11(11):e0166164. doi: 10.1371/journal.pone.0166164. eCollection 2016.
3
Macrophage iron homeostasis and polarization in the context of cancer.癌症背景下巨噬细胞的铁稳态与极化
Immunobiology. 2015 Feb;220(2):295-304. doi: 10.1016/j.imbio.2014.09.011. Epub 2014 Sep 16.
4
Iron Handling in Tumor-Associated Macrophages-Is There a New Role for Lipocalin-2?肿瘤相关巨噬细胞中的铁处理——脂质运载蛋白2有新作用吗?
Front Immunol. 2017 Sep 20;8:1171. doi: 10.3389/fimmu.2017.01171. eCollection 2017.
5
Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages.铁蛋白通过一种非铁依赖的机制刺激乳腺癌细胞,并定位于肿瘤相关的巨噬细胞内。
Breast Cancer Res Treat. 2013 Feb;137(3):733-44. doi: 10.1007/s10549-012-2405-x. Epub 2013 Jan 11.
6
Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.Reptin 在肾细胞癌中的过表达促进了肿瘤的恶性进展,其抑制作用可引发癌细胞衰老。
Urol Oncol. 2013 Oct;31(7):1358-66. doi: 10.1016/j.urolonc.2012.01.004. Epub 2012 Feb 17.
7
Local iron homeostasis in the breast ductal carcinoma microenvironment.乳腺导管癌微环境中的局部铁稳态
BMC Cancer. 2016 Mar 5;16:187. doi: 10.1186/s12885-016-2228-y.
8
Comparative studies of duodenal and macrophage ferroportin proteins.十二指肠和巨噬细胞铁转运蛋白的比较研究。
Am J Physiol Gastrointest Liver Physiol. 2006 Jan;290(1):G156-63. doi: 10.1152/ajpgi.00227.2005. Epub 2005 Aug 4.
9
Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma.转化生长因子-β1抗性的获得:人类肾细胞癌中的一个重要进展因素。
Lab Invest. 1997 May;76(5):739-49.
10
Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.肝癌中浆细胞向 IgG 表型的极化涉及表观遗传改变,并促进小鼠肝癌进展。
Gastroenterology. 2019 May;156(6):1890-1904.e16. doi: 10.1053/j.gastro.2019.01.250. Epub 2019 Jan 31.

引用本文的文献

1
Study on the Photoinduced Isomerization Mechanism of Hydrazone Derivatives Molecular Switch.腙衍生物分子开关的光致异构化机理研究
ACS Omega. 2025 Apr 23;10(17):17898-17906. doi: 10.1021/acsomega.5c00820. eCollection 2025 May 6.
2
Metal Ion Signaling in Biomedicine.生物医学中的金属离子信号传导
Chem Rev. 2025 Jan 22;125(2):660-744. doi: 10.1021/acs.chemrev.4c00577. Epub 2025 Jan 2.
3
Targeting ferroptosis: a new therapeutic opportunity for kidney diseases.靶向铁死亡:肾脏病治疗的新机会。

本文引用的文献

1
The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma.免疫治疗联合方案在晚期肾细胞癌一线治疗中的不断发展。
Front Immunol. 2019 Jan 10;9:3120. doi: 10.3389/fimmu.2018.03120. eCollection 2018.
2
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial.纳武利尤单抗联合伊匹单抗对比舒尼替尼治疗晚期肾细胞癌患者的患者报告结局(CheckMate 214):一项随机、III 期试验。
Lancet Oncol. 2019 Feb;20(2):297-310. doi: 10.1016/S1470-2045(18)30778-2. Epub 2019 Jan 15.
3
Front Immunol. 2024 Jul 3;15:1435139. doi: 10.3389/fimmu.2024.1435139. eCollection 2024.
4
Targeting iron to contrast cancer progression.靶向铁以抑制癌症进展。
Curr Opin Chem Biol. 2023 Jun;74:102315. doi: 10.1016/j.cbpa.2023.102315. Epub 2023 May 13.
5
Clinicopathological study of sarcomatoid renal cell carcinoma in animals in East Java, Indonesia, from 2017 to 2022.2017 年至 2022 年印度尼西亚东爪哇省动物源肉瘤样肾细胞癌的临床病理研究。
Open Vet J. 2023 Jan;13(1):64-73. doi: 10.5455/OVJ.2023.v13.i1.7. Epub 2023 Jan 12.
6
Coordinated reprogramming of renal cancer transcriptome, metabolome and secretome associates with immune tumor infiltration.肾癌转录组、代谢组和分泌组的协同重编程与免疫肿瘤浸润相关。
Cancer Cell Int. 2023 Jan 5;23(1):2. doi: 10.1186/s12935-022-02845-y.
7
The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma.铁调节激素铁调素在肾透明细胞癌中上调,并与不良生存结果相关。
Front Pharmacol. 2022 Dec 2;13:1080055. doi: 10.3389/fphar.2022.1080055. eCollection 2022.
8
Thiol-Reactive Arylsulfonate Masks for Phenolate Donors in Antiproliferative Iron Prochelators.巯基反应性芳基磺酸酯掩蔽酚盐供体在抗增殖铁螯合剂中的应用。
Inorg Chem. 2022 Dec 12;61(49):19974-19982. doi: 10.1021/acs.inorgchem.2c03250. Epub 2022 Dec 1.
9
Comprehensive analysis of immune ferroptosis gene in renal clear cell carcinoma: prognosis and influence of tumor microenvironment.肾透明细胞癌中免疫铁死亡基因的综合分析:预后及对肿瘤微环境的影响
Am J Transl Res. 2022 Sep 15;14(9):5982-6010. eCollection 2022.
10
Aroylhydrazone Glycoconjugate Prochelators Exploit Glucose Transporter 1 (GLUT1) to Target Iron in Cancer Cells.芳酰腙糖缀合物前螯合剂利用葡萄糖转运蛋白1(GLUT1)靶向癌细胞中的铁。
ACS Med Chem Lett. 2022 Aug 18;13(9):1452-1458. doi: 10.1021/acsmedchemlett.2c00250. eCollection 2022 Sep 8.
Iron as a Central Player and Promising Target in Cancer Progression.
铁作为癌症进展中的核心参与者和有前途的靶点。
Int J Mol Sci. 2019 Jan 11;20(2):273. doi: 10.3390/ijms20020273.
4
Iron Metabolism in Cancer.癌症中的铁代谢。
Int J Mol Sci. 2018 Dec 27;20(1):95. doi: 10.3390/ijms20010095.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies.透明细胞肾细胞癌的系统治疗耐药:机制与管理策略。
Mol Cancer Ther. 2018 Jul;17(7):1355-1364. doi: 10.1158/1535-7163.MCT-17-1299.
7
Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment.巨噬细胞衍生的脂质运载蛋白-2在肿瘤微环境中运输铁。
Oncoimmunology. 2017 Dec 22;7(3):e1408751. doi: 10.1080/2162402X.2017.1408751. eCollection 2018.
8
Disulfide-masked iron prochelators: Effects on cell death, proliferation, and hemoglobin production.巯基掩蔽铁螯合剂:对细胞死亡、增殖和血红蛋白生成的影响。
J Inorg Biochem. 2018 Mar;180:186-193. doi: 10.1016/j.jinorgbio.2017.12.016. Epub 2018 Jan 4.
9
Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients.原发性肿瘤中转铁蛋白受体1上调而良性肾组织中转铁蛋白受体1下调与肾细胞癌患者的病情进展及死亡率相关。
Oncotarget. 2017 Nov 6;8(63):107052-107075. doi: 10.18632/oncotarget.22323. eCollection 2017 Dec 5.
10
Evolving Treatment Paradigm in Metastatic Renal Cell Carcinoma.转移性肾细胞癌不断演变的治疗模式
Am Soc Clin Oncol Educ Book. 2017;37:319-329. doi: 10.1200/EDBK_174469.